Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1379 - Provider product page
- Provider
- R&D Systems
- Product name
- Human Reg4 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human Reg4 in direct ELISAs and Western blots. In direct ELISAs and Western blots, this antibody does not cross-react with recombinant mouse (rm) Reg1, rmReg2, recombinant rat (rr) Reg3B, rmReg3A, rrReg3A, or rhReg1B.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
Q9BYZ8
- Isotype
- IgG
- Antibody clone number
- 200214
- Vial size
- 500 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.
Rafa L, Dessein AF, Devisme L, Buob D, Truant S, Porchet N, Huet G, Buisine MP, Lesuffleur T
International journal of oncology 2010 Mar;36(3):689-98
International journal of oncology 2010 Mar;36(3):689-98
REG4 acts as a mitogenic, motility and pro-invasive factor for colon cancer cells.
Rafa L, Dessein AF, Devisme L, Buob D, Truant S, Porchet N, Huet G, Buisine MP, Lesuffleur T
International journal of oncology 2010 Mar;36(3):689-98
International journal of oncology 2010 Mar;36(3):689-98
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.
Mitani Y, Oue N, Matsumura S, Yoshida K, Noguchi T, Ito M, Tanaka S, Kuniyasu H, Kamata N, Yasui W
Oncogene 2007 Jun 28;26(30):4383-93
Oncogene 2007 Jun 28;26(30):4383-93
No comments: Submit comment
No validations: Submit validation data